Critical Review: MediWound (NASDAQ:MDWD) & FitLife Brands (NASDAQ:FTLF)

MediWound (NASDAQ:MDWD) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

Institutional & Insider Ownership

46.8% of MediWound shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 9.2% of MediWound shares are owned by company insiders. Comparatively, 61.3% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares MediWound and FitLife Brands”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediWound	$19.72 million	9.41	-$6.72 million	($2.90)	-5.93
FitLife Brands	$62.76 million	2.02	$5.30 million	$0.84	16.37

FitLife Brands has higher revenue and earnings than MediWound. MediWound is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings for MediWound and FitLife Brands, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediWound	0	0	3	0	3.00
FitLife Brands	0	0	1	1	3.50

MediWound presently has a consensus price target of $31.33, suggesting a potential upside of 82.06%. FitLife Brands has a consensus price target of $20.00, suggesting a potential upside of 45.45%. Given MediWound’s higher probable upside, equities analysts plainly believe MediWound is more favorable than FitLife Brands.

Risk & Volatility

MediWound has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.

Profitability

This table compares MediWound and FitLife Brands’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MediWound	-142.29%	-82.17%	-33.67%
FitLife Brands	13.38%	28.03%	15.13%

Summary

FitLife Brands beats MediWound on 11 of the 15 factors compared between the two stocks.

About MediWound

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

About FitLife Brands

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.